(0.03%) 5 470.92 points
(0.08%) 39 144 points
(0.35%) 17 779 points
(-0.02%) $80.81
(-3.66%) $2.66
(-0.78%) $2 312.60
(0.20%) $28.93
(3.49%) $1 020.80
(0.28%) $0.936
(0.68%) $10.68
(0.43%) $0.792
(-0.27%) $87.25
Live Chart Being Loaded With Signals
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients...
Stats | |
---|---|
Dagens volum | 15.70M |
Gjennomsnittsvolum | 1.70M |
Markedsverdi | 17.18B |
EPS | $2.34 ( Q2 | 2022-11-03 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
65.36 (Sector) 42.63 (Industry) 43.86 |
ATR14 | $4.67 (1.23%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-12-22 | Sutter Martin P | Sell | 123 370 | Common Stock, $0.01 par value |
2022-12-22 | Puhy Dorothy E | Sell | 11 335 | Common Stock, $0.01 par value |
2022-12-22 | Trapp Todd A | Buy | 26 023 | Performance Stock Units |
2022-12-22 | Trapp Todd A | Sell | 26 023 | Performance Stock Units |
2022-12-22 | Plano Matthew T. | Buy | 12 490 | Performance Stock Units |
INSIDER POWER |
---|
-27.52 |
Last 100 transactions |
Buy: 215 643 | Sell: 404 694 |
Volum Korrelasjon
Abiomed, Inc. Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Abiomed, Inc. Korrelasjon - Valuta/Råvare
Abiomed, Inc. Økonomi
Annual | 2022 |
Omsetning: | $1.03B |
Bruttogevinst: | $843.60M (81.76 %) |
EPS: | $3.00 |
FY | 2022 |
Omsetning: | $1.03B |
Bruttogevinst: | $843.60M (81.76 %) |
EPS: | $3.00 |
FY | 2021 |
Omsetning: | $847.52M |
Bruttogevinst: | $685.62M (80.90 %) |
EPS: | $5.00 |
FY | 2020 |
Omsetning: | $840.88M |
Bruttogevinst: | $689.58M (82.01 %) |
EPS: | $4.49 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Abiomed, Inc.
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by interventional cardiologists to support patients in the cath lab, as well as by cardiac surgeons in the heart surgery suite. It also provides Impella 5.0, Impella LD, and Impella 5.5, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump; Impella SmartAssist platform that includes optical sensor technology for improved pump positioning and the use of algorithms that enable improved native heart assessment during the weaning process; Impella Connect, a cloud-based technology that enables secure and remote viewing of the automated impella controller for physicians and hospital staffs; and OXY-1 System, a portable external respiratory assistance device. In addition, the company is developing Impella ECP, a pump for blood flow of greater than three liters per minute; Impella XR Sheath, a sheath that expands and recoils allowing small bore access and closure with Impella heart pumps; Impella BTR, a percutaneous micro heart pump with integrated motors and sensors; and preCARDIA, a catheter-mounted superior vena cava therapy system designed to rapidly treat acutely decompensated heart failure. Abiomed, Inc. sells its products through direct sales and clinical support personnel in the Germany, France, United States, Japan, Europe, Canada, Latin America, the Asia-Pacific, and the Middle East. The company was founded in 1981 and is headquartered in Danvers, Massachusetts. As of December 22, 2022, Abiomed, Inc. operates as a subsidiary of Johnson & Johnson.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.